CEO Sang Ryong Kim was reported in the News for the Research Achievement 'Journal of Neuroinflammation(IF = 10.1)' > News

NeuroVita-Lab

NeuroVita-Lab Inc. is a specialized research-driven organization dedicated to overcoming degenerative central nervous system (CNS) diseases and sarcopenia. By leveraging advanced disease-specific animal models, we lead the development of innovative therapies and provide scientific solutions to address the complexities of brain aging.

CEO Sang Ryong Kim was reported in the News for the Research Achieveme…

페이지 정보

작성자 최고관리자 이메일 admin@domain.com 작성일 2026-04-27

본문

Professor Sang Ryong Kim, CEO of NeuroVita-Lab Inc., was reported in the news for the research achievement 'Journal of Neuroinflammation(IF = 10.1)' on April 27, 2026.

CEO Sang Ryong Kim selected for the ‘2026 Brain Science Leading Convergent Technology Development Project’

26.05.08

Completion of Basic Preclinical CRO Services [Efficacy Evaluation of New Drug Candidate for Neurodegenerative Diseases: Astrogen Inc.] and Submission of Final Report

26.04.10